Jörg Schulze
About Jörg Schulze
Jörg Schulze is the Executive Director and Business Unit Lead Oncology at Bristol-Myers Squibb in New York, with a background in virology, immunology, and rheumatology across various global pharmaceutical companies.
Company
Jörg Schulze is currently employed at Bristol-Myers Squibb in New York, New York, United States. At Bristol-Myers Squibb, he holds the position of Executive Director and Business Unit Lead Oncology. Previously, he served as Business Unit Director Virology at the same company from 2013 to 2016.
Executive Director and Business Unit Lead Oncology
In his current role at Bristol-Myers Squibb, Jörg Schulze leads the oncology business unit. He has overseen the launch of multiple oncology products which have significantly boosted the company's oncology portfolio. His responsibilities include strategic planning and the establishment of partnerships with leading cancer research institutions.
Previous Roles and Experience
Jörg Schulze has an extensive background in the pharmaceutical industry. Before his current role, he was the Business Unit Director Virology at Bristol-Myers Squibb. He has also held key positions at Abbvie and Abbott, dealing with immunology, rheumatology, and product management. These roles included Head of Business Unit Immunology, Business Unit Manager Immunology, Marketing Manager, Product Manager, and Sales Representative across locations in Germany, Switzerland, and the United States.
Education and Expertise
Jörg Schulze holds a Doctorate in Philosophy from the University of Cologne, completed between 2002 and 2006. Additionally, he studied at Harvard Medical School for one year and spent seven years at the University of Kaiserslautern. His academic background supports his extensive knowledge and leadership capabilities in oncology and other medical fields.
Achievements
Jörg Schulze is noted for his role in launching oncology products that have driven significant growth at Bristol-Myers Squibb. He has been a keynote speaker at international oncology conferences and has published multiple research papers in renowned medical journals. He is also engaged in mentoring young professionals and researchers in oncology through various industry programs.